Development and optimization of high-throughput methods to measure Plasmodium falciparum-specific growth inhibitory antibodies.
about
Plasmodium falciparum merozoite invasion is inhibited by antibodies that target the PfRh2a and b binding domainsA genetic screen for attenuated growth identifies genes crucial for intraerythrocytic development of Plasmodium falciparumDeletion of the Plasmodium falciparum merozoite surface protein 7 gene impairs parasite invasion of erythrocytesPlasmodium falciparum ligand binding to erythrocytes induce alterations in deformability essential for invasionAn EGF-like protein forms a complex with PfRh5 and is required for invasion of human erythrocytes by Plasmodium falciparumSystematic genetic analysis of the Plasmodium falciparum MSP7-like family reveals differences in protein expression, location, and importance in asexual growth of the blood-stage parasiteMacrolides rapidly inhibit red blood cell invasion by the human malaria parasite, Plasmodium falciparum.Epigenetic silencing of Plasmodium falciparum genes linked to erythrocyte invasion.Monitoring Plasmodium falciparum growth and development by UV flow cytometry using an optimized Hoechst-thiazole orange staining strategy.Acquisition of growth-inhibitory antibodies against blood-stage Plasmodium falciparum.Antibody-mediated growth inhibition of Plasmodium falciparum: relationship to age and protection from parasitemia in Kenyan children and adultspiggyBac is an effective tool for functional analysis of the Plasmodium falciparum genomeClinical protection from falciparum malaria correlates with neutrophil respiratory bursts induced by merozoites opsonized with human serum antibodiesIn vitro growth-inhibitory activity and malaria risk in a cohort study in maliDevelopment of fluorescent Plasmodium falciparum for in vitro growth inhibition assaysQuantitative proteomics reveals new insights into erythrocyte invasion by Plasmodium falciparumTransplacentally transferred functional antibodies against Plasmodium falciparum decrease with age.Isolation of viable Plasmodium falciparum merozoites to define erythrocyte invasion events and advance vaccine and drug development.Quantifying the importance of MSP1-19 as a target of growth-inhibitory and protective antibodies against Plasmodium falciparum in humans.The Plasmodium falciparum erythrocyte invasion ligand Pfrh4 as a target of functional and protective human antibodies against malaria.Comparative analysis of IgG responses to Plasmodium falciparum MSP1p19 and PF13-DBL1α1 using ELISA and a magnetic bead-based duplex assay (MAGPIX®-Luminex) in a Senegalese meso-endemic community.Defining the antigenic diversity of Plasmodium falciparum apical membrane antigen 1 and the requirements for a multi-allele vaccine against malaria.Efficient measurement of opsonising antibodies to Plasmodium falciparum merozoitesReticulocyte and erythrocyte binding-like proteins function cooperatively in invasion of human erythrocytes by malaria parasitesMethodology and application of flow cytometry for investigation of human malaria parasites.Antibodies to polymorphic invasion-inhibitory and non-Inhibitory epitopes of Plasmodium falciparum apical membrane antigen 1 in human malaria.Vaccination with conserved regions of erythrocyte-binding antigens induces neutralizing antibodies against multiple strains of Plasmodium falciparum.Overcoming antigenic diversity by enhancing the immunogenicity of conserved epitopes on the malaria vaccine candidate apical membrane antigen-1.Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against malariaCCR4-associated factor 1 coordinates the expression of Plasmodium falciparum egress and invasion proteins.Discovery of GAMA, a Plasmodium falciparum merozoite micronemal protein, as a novel blood-stage vaccine candidate antigen.Recognition of Human Erythrocyte Receptors by the Tryptophan-Rich Antigens of Monkey Malaria Parasite Plasmodium knowlesi.Protective Effect of Chronic Schistosomiasis in Baboons Coinfected with Schistosoma mansoni and Plasmodium knowlesi.Plasmodium falciparum line-dependent association of in vitro growth-inhibitory activity and risk of malaria.A novel approach to identifying patterns of human invasion-inhibitory antibodies guides the design of malaria vaccines incorporating polymorphic antigens.Targets of antibodies against Plasmodium falciparum-infected erythrocytes in malaria immunity.Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies.Quantitative determination of Plasmodium parasitemia by flow cytometry and microscopy.Can growth inhibition assays (GIA) predict blood-stage malaria vaccine efficacy?Contrasting Patterns of Serologic and Functional Antibody Dynamics to Plasmodium falciparum Antigens in a Kenyan Birth Cohort
P2860
Q27230103-EDAA6A57-0A30-4E1A-848B-340460F3ABDDQ28475727-47F673A7-3BD6-42F3-AB21-2C70996E44CFQ30042482-9CB1D88A-7725-459E-B5A5-E40FF262EB42Q30042563-DEC5C796-094D-48E7-9041-FDB93D67CCE2Q30043132-D4AE3039-6624-4E30-B759-71EA8F447A52Q30044844-AE6ED71C-5032-43B4-A02F-4F7D41FEF824Q30658099-81C69863-B6C2-452A-98A5-9BC3B46A0F25Q33293155-106FE1C8-FDF0-4A48-A87E-C5E8A43D7B63Q33321282-143F1118-9F53-4628-8500-A0DFA3707857Q33380204-11B38155-391F-4342-BBCB-A097AE93D503Q33380213-137A5C5E-6463-4372-9AB9-282809AEDAEEQ33440887-4A97DCC6-627E-49DF-BC41-E7E1F410AC23Q33548663-24BC01A0-D9AB-44CB-BB21-C229DA09AC04Q33613892-A0B9F5C1-1305-4C6F-9F81-1844B15C1127Q33939788-89393D2B-6D48-4AF3-8B34-00FDB8DB8BC9Q34056710-D89E1C2E-060B-44E0-82E1-E3F2F9D0DFC8Q34060022-744BE9B2-D32F-4DEC-B08E-0304CB64C3A4Q34069682-D4B4D067-3CDD-43AD-963C-341BE6576991Q34081745-C1020A7F-1416-49F3-8F13-AD14630324A3Q34428497-6A5998C0-08C0-47FA-BAC6-586F257E118DQ34460065-5DBFD3CD-BDD3-499C-BD17-13FBA82C34C7Q34507190-EE53B3D6-9386-4C56-9C31-A278FFCAB087Q34540211-A8A076D5-7128-4130-BB25-22C65C07DF58Q34739631-FD40FD18-C0E2-4298-B99E-852F11A695D5Q34765400-1D69EB63-3EA4-470C-9676-FF441FE02790Q34827195-AEC54B40-29A5-46A4-9AE2-F0477820179AQ34988452-AFF190AE-4819-4D8A-BEB7-A87C8109129CQ35079832-CBE474F0-A01F-4003-87BA-9820E8003CB4Q35213495-C7021A27-E603-4CA5-B6A8-DD83FAF42A55Q35271315-964EED2B-8E0B-4338-8460-BDBE6A988FF1Q35671610-FF368A9D-C3C3-4322-9EC8-5DC306D8D299Q35782962-55461767-C8E1-41E2-B7C8-B7BC5522CCD1Q35925405-3DC0FBFD-7459-42CF-B555-ACE89A4726D2Q35944117-45CADB63-8938-412F-80B5-248F4ECCD4CEQ36141540-89EB6531-ED03-4C19-BA88-C8ADCA240D63Q36190707-BC5AA5F7-D205-4EF4-85AD-6E5195FEE39CQ36227228-C5CDCE77-7FBC-4FF5-8EA5-8B244C8F4679Q36310065-BE3FB20B-491B-4733-B895-41C25FD349EAQ36391845-31B26C57-10FC-4206-BA23-54ED738A0E9CQ36555103-6FB8FEE2-A4C0-412C-935F-BB7869BBBD8D
P2860
Development and optimization of high-throughput methods to measure Plasmodium falciparum-specific growth inhibitory antibodies.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Development and optimization o ...... growth inhibitory antibodies.
@ast
Development and optimization o ...... growth inhibitory antibodies.
@en
Development and optimization o ...... growth inhibitory antibodies.
@nl
type
label
Development and optimization o ...... growth inhibitory antibodies.
@ast
Development and optimization o ...... growth inhibitory antibodies.
@en
Development and optimization o ...... growth inhibitory antibodies.
@nl
prefLabel
Development and optimization o ...... growth inhibitory antibodies.
@ast
Development and optimization o ...... growth inhibitory antibodies.
@en
Development and optimization o ...... growth inhibitory antibodies.
@nl
P2860
P1476
Development and optimization o ...... growth inhibitory antibodies.
@en
P2093
Chee T Lee
Kristina E M Persson
P2860
P304
P356
10.1128/JCM.44.5.1665-1673.2006
P407
P577
2006-05-01T00:00:00Z